Oohlala, a Canada-based edtech developer, has raised C$5.3m ($4m) in funding led by spinout-focused investment firm University Ventures. The round also featured GoAhead Ventures, a fund backed by a range of Japan-based universities, accelerator Y Combinator, Real Ventures and assorted angel investors. The startup, founded by Toronto University graduates, has developed software to increase student engagement. The company’s platform also exposes students to extracurricular activities and career opportunities.
Allinaire, a spinout of Indiana University focused on pulmonary diseases, has received an undisclosed sum from Innovate Indiana Fund, a vehicle of Indiana University, as well as BioMotiv, a biomedical accelerator affiliated with the Harrington Project for Discover and Development, and the Indiana Seed Fund II, managed by BioCrossroads. The spinout is based on research by Matthias Clauss, associate research professor at the university’s School of Medicine, and Irina Petrache, chief of the Division of Pulmonology, Critical Care and Sleep Medicine, National Jewish Health. Allinaire has also obtained a grant from National Institutes of Health through the Small Business Innovation & Research program.
Valo Therapeutics, an oncology spinout of Helsinki University, has closed a seed round of undisclosed size provided by unnamed backers. The spinout is based on research by Vincenzo Cerullo, head of the drug research program at the Faculty of Pharmacy. Valo is working on viral vaccines to treat several forms of cancer. The funding will be used to support pre-clinical development of a lead candidate.
